Dal Pan GJ - Search Results

1

Measures to quantify the abuse of prescription opioids: a review of data sources and metrics.

Secora AM, Dormitzer CM, Staffa JA, Dal Pan GJ. Secora AM, et al. Among authors: dal pan gj. Pharmacoepidemiol Drug Saf. 2014 Dec;23(12):1227-37. doi: 10.1002/pds.3711. Epub 2014 Sep 25. Pharmacoepidemiol Drug Saf. 2014. PMID: 25257660 Review.

2

Duration of therapy with metoclopramide: a prescription claims data study.

Kaplan S, Staffa JA, Dal Pan GJ. Kaplan S, et al. Among authors: dal pan gj. Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):878-81. doi: 10.1002/pds.1397. Pharmacoepidemiol Drug Saf. 2007. PMID: 17436356

3

The concomitant prescribing of ethinyl estradiol/drospirenone and potentially interacting drugs.

McAdams M, Staffa JA, Dal Pan GJ. McAdams M, et al. Among authors: dal pan gj. Contraception. 2007 Oct;76(4):278-81. doi: 10.1016/j.contraception.2007.06.002. Epub 2007 Aug 1. Contraception. 2007. PMID: 17900437

4

Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.

McAdams M, Staffa J, Dal Pan G. McAdams M, et al. Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):229-39. doi: 10.1002/pds.1535. Pharmacoepidemiol Drug Saf. 2008. PMID: 18175291

5

Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs.

Hammad TA, Graham DJ, Staffa JA, Kornegay CJ, Dal Pan GJ. Hammad TA, et al. Among authors: dal pan gj. Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):315-21. doi: 10.1002/pds.1560. Pharmacoepidemiol Drug Saf. 2008. PMID: 18302311

6

Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: revisiting the Weber effect.

McAdams MA, Governale LA, Swartz L, Hammad TA, Dal Pan GJ. McAdams MA, et al. Among authors: dal pan gj. Pharmacoepidemiol Drug Saf. 2008 Sep;17(9):882-9. doi: 10.1002/pds.1633. Pharmacoepidemiol Drug Saf. 2008. PMID: 18636418

7

Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database.

Hammad TA, McAdams MA, Feight A, Iyasu S, Dal Pan GJ. Hammad TA, et al. Among authors: dal pan gj. Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1197-201. doi: 10.1002/pds.1672. Pharmacoepidemiol Drug Saf. 2008. PMID: 18985705

8

Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.

McMahon AW, Pratt RG, Hammad TA, Kozlowski S, Zhou E, Lu S, Kulick CG, Mallick T, Dal Pan G. McMahon AW, et al. Pharmacoepidemiol Drug Saf. 2010 Sep;19(9):921-33. doi: 10.1002/pds.1991. Pharmacoepidemiol Drug Saf. 2010. PMID: 20661880

9

Commentary on "Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting" by Linder et al.

Dal Pan GJ. Dal Pan GJ. Pharmacoepidemiol Drug Saf. 2010 Dec;19(12):1216-7. doi: 10.1002/pds.2050. Pharmacoepidemiol Drug Saf. 2010. PMID: 20981885 No abstract available.

10

Regulatory innovation in postmarketing risk assessment and management.

Staffa JA, Dal Pan GJ. Staffa JA, et al. Among authors: dal pan gj. Clin Pharmacol Ther. 2012 Mar;91(3):555-7. doi: 10.1038/clpt.2011.289. Epub 2012 Feb 1. Clin Pharmacol Ther. 2012. PMID: 22297386

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters